New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants

類似資料

• Performance of a Redesigned HIV Selectest Enzyme-Linked Immunosorbent Assay Optimized To Minimize Vaccine-Induced Seropositivity in HIV Vaccine Trial Participants
  著者:: Penezina, Oksana, 等
  出版事項: (2014)
• Vaccine-Induced HIV Seropositivity/Reactivity in Noninfected HIV Vaccine Recipients
  著者:: Cooper, Cristine J., 等
  出版事項: (2010)
• Issues in Women's Participation in a Phase III Community HIV Vaccine Trial in Thailand
  著者:: Kaewkungwal, Jaranit, 等
  出版事項: (2013)
• Analysis of HIV seropositive thalassemic children for antibodies specific to Aspergillus fumigatus by luminescent immunoassay
  著者:: Sharma, G. L., 等
  出版事項: (1998)
• HIV Vaccine-Induced Sero-Reactivity: A Challenge for Trial Participants, Researchers, and Physicians
  著者:: Voronin, Yegor, 等
  出版事項: (2015)